Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03560596 · ClinicalTrials.gov registry record · NA

Helping Hypertensive Latinos to Improve Medication Adherence

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
119
Enrollment target

NCT03560596 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 119 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03560596, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target

Study Summary

Poor medication adherence is a major contributor to inadequate BP control, and is associated with 125,000 deaths annually. Translation of adherence interventions to community-based primary care practices where majority of Latino patients receive care is non-existent. Thus, the development of tailored interventions targeted at improving medication adherence in the Latino population is needed in order to address the racial disparities in BP control between Latinos and whites. This proposal provides a unique opportunity to address this gap in the literature. Using a randomized control design (RCT), the study will evaluate the effect of a culturally tailored, practice-based intervention on medication adherence in 148 high-risk Latino patients with uncontrolled HTN. To facilitate translation into routine practices, the intervention will be integrated into the clinic's electronic medical record (EMR) system, and will be delivered by trained, bilingual Health Coaches.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Adherence Intervention

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2013-04-04
Est. Completion 2017-08-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03560596

The ClinicalTrials.gov registry entry for NCT03560596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT03560596 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03560596 about?

NCT03560596 is a clinical study titled "Helping Hypertensive Latinos to Improve Medication Adherence". Poor medication adherence is a major contributor to inadequate BP control, and is associated with 125,000 deaths annually. Translation of adherence interventions to community-based primary care practices where majority of Latino patients receive care is non-existent. Thus, the development of tailore...

What is the current status of trial NCT03560596?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2013-04-04. Estimated completion is 2017-08-01.

What interventions are being tested in trial NCT03560596?

The interventions under investigation include: Usual Care (BEHAVIORAL), Adherence Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03560596?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.